Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Internal Medicine Journal|December 20, 2020
Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS-QI 54)Fang Shawn Foo, Katrina K Poppe, Mildred Lee, et al.
Internal Medicine Journal|October 18, 2020
Ten-year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51)Fang Shawn Foo, Martin K Stiles, Mildred Lee, et al.
The Lancet. Digital Health|June 3, 2025
Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk modelShishir Rao, Yikuan Li, Mohammad Mamouei, et al.
Open Heart|January 28, 2022
Prehospital identification of ST-segment elevation myocardial infarction and mortality (ANZACS-QI 61)Becky Yi-Wen Liao, Mildred Ai Wei Lee, Bridget Dicker, et al.
The Lancet. Healthy Longevity|January 14, 2022
The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary careEmily Herrett, Helen Strongman, Sarah Gadd, et al.
The New Zealand Medical Journal|June 21, 2022
Ethnic variation in the trends of new implantable cardioverter defibrillator implants in New Zealand 2005-2019 (ANZACS-QI 63)Fang Shawn Foo, Mildred Lee, Katrina K Poppe, et al.
Journal of Arrhythmia|February 20, 2020
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33)Fang Shawn Foo, Mildred Lee, Khang-Li Looi, et al.
Congestive Heart Failure (Greenwich, Conn.)|April 24, 2010
The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve diseaseNaylin Bissessor, Luke Shanahan, Yong Shen Wee, et al.
Heart (British Cardiac Society)|August 3, 2023
Widening ethnic inequities in heart failure incidence in New ZealandDaniel Zl Chan, Corina Grey, Rob N Doughty, et al.
ACS Chemical Neuroscience|February 9, 2024
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole ScaffoldClelia Dallanoce, Katrin Richter, Clare Stokes, et al.
Pageof 27